At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy
In Brief
A Phase 2 clinical trial evaluating Milk Protein Extract Immunotherapy goal of 4mg/day, Milk Protein Extract Immunotherapy goal of 7mg/day, and 2 other interventions for Milk Allergy. Completed, enrolled 30 participants across 2 sites.
Detailed Summary
The purpose of this study is to determine if small oral and sublingual doses of milk protein are safe and effective in decreasing sensitivity to cow's milk in allergic children.
Study Details
Timeline
Interventions
Sublingual extract given daily in escalating doses with goal of 4 mg/day for approximately 20 weeks.
Sublingual extract daily in escalating doses to goal of 7mg/day for approximately 1 1/2 years.
Milk powder given orally in escalating doses with a goal dose of 2000mg/day given for approximately 1 1/2 years.
Milk powder given orally in escalating doses with a goal of 1000mg/day for approximately 1 1/2 years.